Callum George Fraser

Biography

Professor Fraser graduated BSc and PhD from the University of Aberdeen.  After a year of postdoctoral work in the National Research Council of Canada in Ottawa, he returned to the University of Aberdeen as Lecturer in Chemical Pathology.  From 1975, he was Chief Clinical Biochemist at the then new Flinders Medical Centre in South Australia and Honorary Senior Lecturer in Clinical Biochemistry in the Flinders University of South Australia, later Associate Professor.  He returned to Scotland in 1983 and was Director of Biochemical Medicine, NHS Tayside, and Honorary Senior Lecturer in the Universities of Dundee and St Andrews. He is currently Senior Research Fellow, Scottish Bowel Screening Research Unit; Honorary Professor, Centre for Research into Cancer Prevention and Screening, University of Dundee, and Honorary Consultant Clinical Biochemist, NHS Tayside. He has published over 300 papers, 13 book chapters and two monographs, *Interpretation of Clinical Chemistry Laboratory Data” and the best-selling “Biological Variation: From Principles to Practice”: both books have been translated into Spanish and the second into Japanese, Russian, Italian and Turkish also.  He has served on many regional, national and international professional bodies.  Over the last 15 years, he has been heavily involved in the setting up of the UK Colorectal Cancer Screening Pilot, the development and roll-out of the Scottish Bowel Screening Programme and the assessment of newer faecal tests.  He is a founding Member of the Expert Working Group on Faecal Immunochemical Tests for Screening of the Colorectal Cancer Screening Committee, World Endoscopy Organization. He has been honoured by the Foundation Award and Honorary Membership of the Association for Clinical Biochemistry and Laboratory Medicine. He has also been honoured with the European Federation of Clinical Chemistry and Laboratory Medicine award for important achievements as a scientist in laboratory medicine.  

Research Interest

Current research interests include: Assessment of newer faecal tests in colorectal cancer screening and assessment of patients with lower abdominal symptoms: Making better use of quantitative measurements of faecal haemoglobin concentration including in risk scoring systems: Generation and application of data on biological variation.